Nationwide Chemists Strike Against E-Pharmacy Today: 12.4 Lakh Pharmacies Shut Over Online Medicine Sales Concerns | AIOCD Protest 2026
Nationwide Chemists Strike Against E-Pharmacy: Over 12.4 Lakh Pharmacies Close Doors on May 20, 2026
In a significant development shaking India’s pharmaceutical retail sector, over 12.4 lakh chemists and druggists across the country have shut their shops today, May 20, 2026, as part of a 24-hour nationwide strike called by the All India Organisation of Chemists and Druggists (AIOCD). The protest highlights deep concerns over the unregulated growth of e-pharmacy platforms, alleged threats to public health, and the survival of traditional brick-and-mortar pharmacies.
This massive shutdown, supported strongly in states like Bihar, has raised fears of temporary disruptions in medicine supply, though authorities and several chains assure that essential services remain operational. The strike brings the long-simmering debate over e-pharmacy regulation in India to the forefront, with traditional retailers demanding stricter oversight to protect both their businesses and consumers.
Why Are Chemists Striking Against E-Pharmacy?
The AIOCD and supporting associations argue that e-pharmacy platforms operate in a “legal grey zone.” Online delivery of medicines was initially permitted only as a temporary measure during the COVID-19 pandemic. However, many platforms continue to function without a comprehensive, finalized regulatory framework, raising serious red flags.
Parsan Kumar Singh, vice-president of AIOCD’s eastern zone, emphasized: “This movement is aimed at protecting our business, safeguarding public health, and preserving the integrity of the pharmaceutical distribution system.” He alleged that e-pharmacies exploit emergency relaxations, leading to inadequate prescription verification, storage issues during delivery, and risks of counterfeit drugs entering the supply chain.
Key demands and concerns include:
- Misuse of Prescription Drugs: Easy online access to antibiotics, habit-forming drugs, narcotics, and Schedule H medicines without proper verification. This contributes to antimicrobial resistance, drug misuse, and societal harm.
- Predatory Pricing and Deep Discounts: Online platforms offer heavy discounts that offline retailers cannot match (typically limited to around 10%). This threatens the viability of small pharmacy owners, especially in rural and semi-urban areas.
- Patient Safety and Quality Control: Questions over storage conditions during home delivery, potential for fake or reused prescriptions, and lack of pharmacist counseling.
- Threat to Traditional Business: Nearly 40,000 chemists in Bihar, including 7,000 in Patna district, are participating. Nationwide, the strike affects the livelihood of millions dependent on the sector.
AK Sinha, a pharmacy owner on Boring Canal Road in Patna, noted that many customers shifted to online platforms post-pandemic due to convenience and discounts, but offline stores struggle to compete.
Scale of the Strike: Bihar and Nationwide Impact
In Bihar, the Bihar Chemists and Druggists Association is actively supporting the AIOCD call. Protests are scheduled on GM Road in Patna from 10 am to 1 pm, with similar demonstrations at district headquarters. Organizers expect near-total participation from independent pharmacies.
Nationwide, the AIOCD represents a vast network. While exact participation varies by state, the strike is one of the largest in recent years for the sector. However, not all associations are on board. Several state-level bodies from West Bengal, Kerala, Punjab, Maharashtra, Karnataka, Haryana, Uttar Pradesh, Ladakh, Gujarat, Chhattisgarh, Sikkim, and Uttarakhand have opted out, citing public interest and committing to keep shops open.
Who Remains Open? Emergency Services and Major Chains Unaffected
To minimize public inconvenience, key exemptions apply:
- Hospital-attached pharmacies and emergency medical services continue operating.
- Major pharmacy chains remain open.
- Pradhan Mantri Jan Aushadhi Kendras and AMRIT outlets function normally.
- In Tamil Nadu, around 5,000 pharmacies (including hospital, chain, cooperative, and CM’s outlets) stay open, with district-wise helplines set up. Details are available on drugscontrol.tn.gov.in.
Government sources and the Central Drugs Standard Control Organisation (CDSCO) have assured citizens of minimal disruption. AIOCD representatives recently met the national drug regulator, which confirmed that concerns regarding e-pharmacy operations are under active review.
The Regulatory Grey Zone of E-Pharmacy in India
The core issue revolves around the absence of finalized rules for online medicine sales. The 2018 Draft Rules (GSR 817(E)) proposed a framework for registration, prescription handling, inspections, and data privacy, but they remain pending for years. A Delhi High Court stay and ongoing consultations have left the sector in limbo.
Critics of e-pharmacy argue this vacuum allows platforms to bypass norms that traditional chemists must follow strictly, such as physical prescription checks and licensed pharmacist oversight. Supporters highlight benefits like doorstep delivery for remote patients, better access in underserved areas, and competitive pricing.
This strike reignites discussions on balancing innovation with safety. Issues like AI-generated fake prescriptions, reuse of old scripts, and aggressive marketing have amplified worries about public health, especially in a country battling high antibiotic misuse.
Impact on Consumers and Small Businesses
For the average citizen, today’s strike means planning ahead for routine medicines. Authorities advise stocking essentials in advance. Rural areas, where local chemists often serve as primary healthcare touchpoints, may feel the pinch more.
Small pharmacy owners like those in Patna fear long-term extinction due to e-pharmacy dominance. “Offline retailers can provide up to 10% discount… anything more does not seem feasible,” said AK Sinha. This pricing war, combined with high operational costs for physical stores (rent, staff, compliance), squeezes margins.
On the flip side, e-pharmacy has democratized access for many, particularly elderly, disabled, or those in remote locations. The challenge lies in responsible regulation that harnesses technology without compromising safety or fairness.
Broader Context: Evolution of Pharmacy Retail in India
India’s pharma market is massive, with retail pharmacies forming its backbone. The post-COVID digital shift accelerated e-pharmacy adoption, but it also exposed regulatory gaps. Traditional chemists have been vocal about threats to the established distribution network, which ensures last-mile connectivity even in challenging terrains.
The AIOCD has warned that unchecked expansion could lead to monopolization by large corporates, weakening the decentralized model that supports millions of jobs and reliable supply in villages.
Government and Stakeholder Response
The CDSCO and health ministry are examining the sector. Recent meetings with AIOCD signal that stakeholder inputs are being considered for a balanced policy. States like Tamil Nadu have proactively set up helplines and identified open outlets.
Experts suggest future regulations could include mandatory Aadhaar-linked prescriptions, real-time verification systems, strict storage/delivery protocols, periodic audits, and clear guidelines on discounts to create a level playing field.
What Happens Next? Potential Outcomes of the Strike
As the strike unfolds today, monitoring its impact will be key. If participation is high in key states, it could pressure faster regulatory action. Conversely, widespread opt-outs by state associations may limit national disruption but still spotlight the e-pharmacy issue.
For consumers: Check local hospital pharmacies, Jan Aushadhi stores, or major chains. Use state helplines for emergencies. For pharmacists: The unified voice underscores the need for dialogue between traditional retailers, digital players, and regulators.
This nationwide chemists strike against e-pharmacy is more than a one-day bandh—it reflects deeper tensions in India’s evolving healthcare ecosystem. As technology transforms medicine access, ensuring safety, equity, and sustainability remains paramount.
The coming weeks will likely see intensified discussions, possible policy updates, and continued advocacy from all sides. For the latest updates on medicine availability, e-pharmacy regulations, and strike impacts in your region, stay tuned to reliable sources and official government advisories.
